Rx for Biotech

著者： Podcast Host Chris Leidli
無料で聴く

  • サマリー

  • The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts and industry leaders developing advanced therapies and enabling technologies including physicians, healthcare providers, patient advocates, and biopharma leaders.
    All rights reserved
    続きを読む 一部表示

あらすじ・解説

The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts and industry leaders developing advanced therapies and enabling technologies including physicians, healthcare providers, patient advocates, and biopharma leaders.
All rights reserved
経済学
続きを読む 一部表示
エピソード
  • How NGGT is Pioneering the Next Wave of Gene Therapies

    How NGGT is Pioneering the Next Wave of Gene Therapies
    2024/10/10
    Next Generation Gene Therapies is developing novel gene therapies for the treatment of many rare diseases. In this podcast episode, the company's Co-Founder and Chief Operating Officer, Guang Qu, discusses how the company's dual-functional vector tech platform is being used to target many diseases.
    続きを読む 一部表示
    40 分
  • Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

    Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker
    2024/09/18
    Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-007 with President and CEO, Aron Knickerbocker. Link to Interleukin-2 review article can be found here: https://www.nature.com/articles/s41587-022-01390-3
    続きを読む 一部表示
    38 分
  • Left Behind: Addressing Health Equity for the Rare Disease Patient Community

    Left Behind: Addressing Health Equity for the Rare Disease Patient Community
    2024/09/09
    In this podcast episode, we discuss the importance of addressing health equity for the rare disease community with Tamar Thompson, Head of Corporate Affairs at Alexion, AstraZeneca Rare Disease. Tamar discussed her efforts to champion health policy, advocacy, equity, and awareness for rare diseases. Link to NMOSD video mentioned in episode: https://www.youtube.com/playlist?list=PLJQx_6LtucSB9GGeiWTycLm7wjK_LX0ZI
    続きを読む 一部表示
    21 分

Rx for Biotechに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。